Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QD8U | ISIN: US87650L1035 | Ticker-Symbol:
NASDAQ
17.01.25
21:59 Uhr
46,560 US-Dollar
-0,360
-0,77 %
1-Jahres-Chart
TARSUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TARSUS PHARMACEUTICALS INC 5-Tage-Chart
ACCESS Newswire
541 Leser
Artikel bewerten:
(2)

Tarsus Redefines Financial Strategy by Combining Innovative Outsourced Accounting, CFO, Finance, and Transaction Services

Finanznachrichten News

WASHINGTON, DC / ACCESSWIRE / March 4, 2024 / Tarsus, a trailblazing accounting, financial, and transaction services firm, is proud to announce its official re-branding and expanding industry and service line expertise to become a one-stop finance and accounting solution.

Tarsus Logo

Tarsus Logo
VentureCount, RTA Group, California Business Solutions, AdminAssist, GovCon Accountants, and Tarsus CFO - are now Tarsus. For over 20 years, Tarsus has worked with businesses of all sizes and industries across the US.

VentureCount, RTA Group, California Business Solutions, AdminAssist, GovCon Accountants, and Tarsus CFO - are now Tarsus. For over 20 years, Tarsus has worked with businesses of all sizes and industries across the US.

As Tarsus, we are a leading advisory firm in personalized outsourced CFO services, M&A, accounting, payroll, finance, and transactional services designed to help you scale your business and build value by providing access to unparalleled financial experts. Our industry focus includes emerging growth companies (private equity and venture capital funded businesses), health & consumer services, industrial and manufacturing, professional & business services, technology, and high growth, from early stage to the middle market.

Tarsus has two specialized divisions exclusive to government contractors and staffing agencies: GovCon and AdminAssist. Our GovCon division provides complete turnkey, full-service FAR/DCAA-compliant managed accounting services to government contractors nationwide. AdminAssist offers specialized services for staffing agencies, which include accounting, payroll, invoicing, CFO services, and more.

In an era where financial stability is paramount, Tarsus steps forward as a strategic partner for companies seeking to fortify their financial foundations. The outsourced accounting and financial intelligence services offered by Tarsus are tailor-made to address businesses' unique challenges while lessening financial burdens. In particular, our fractional and interim CFO services go beyond traditional financial management, allowing us to act as a strategic partner who can spur growth and equity value by leveraging industry-specific insights. Coupled with our recurring accounting services, you will have the right data at the right time.

We stand apart with our commitment to simplifying accounting and finance, allowing you to focus on your business's core competencies while leaving the intricacies of financial management to our team of seasoned experts. Our company's approach is rooted in the belief that a streamlined financial infrastructure can act as a catalyst for sustained success for your company, in addition to safeguarding against audits.

Key highlights of the Tarsus's Financial Intelligence suite include:

  • Accounting & Reporting Services: Bookkeeping, Accounting, Controller Services
  • Compliance, Tax, & Payroll: Audit Preparation & Support, Payroll Services, Tax Planning, Compliance, Credits & Advisory
  • Financial Management & Strategy: CFO Services; Support & Advisory, Financial Planning & Analysis
  • Transaction Services: M&A Advisory & Support, Capital & Funding Support

In a rapidly evolving business landscape, Tarsus emerges as a beacon of financial expertise and provides a roadmap for financial empowerment. We offer over two decades of industry experience and in-depth knowledge of best practices, financial strategy, GAAP accounting, tax credits, FAR/DCAA compliance accounting for government contractors, and much more.

If your business aspires to navigate the intricate world of accounting and finance with precision, Tarsus is the partner that can help transform challenges and roadblocks into opportunities.

For media inquiries or to learn more about Tarsus and our services, please contact:

Lorenna Feliz Santos
Media Relations Contact
lorenna.felizsantos@tarsus.pro
954-599-4430

About Tarsus

Tarsus is a leading accounting and financial firm that offers outsourced CFO services, M&A, accounting, payroll, finance, and transactional services. With a commitment to simplifying finance and empowering businesses, Tarsus provides strategic solutions to build equity, streamline operations, and navigate the complexities of the financial landscape with confidence. For more information, visit www.tarsus.pro.

Contact Information:

Lorenna Feliz Santos
Media Relations
lorenna.felizsantos@tarsus.pro
9545994430

SOURCE: Tarsus

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.